Cv Sciences, Inc. (CVSI) intrinsic value & 10-year financials

Cv Sciences, Inc. (CVSI) has a Graham intrinsic value of $0.23 per share. At $0.01 on Oct 17, 2026, the stock trades 96% below that value. Over the last 10 fiscal years revenue grew 2.5% a year to $13.8M, with an average return on invested capital of -15.1%.

Graham intrinsic value
$0.23
Share price (Oct 17, 2026)
$0.01
Price vs Graham value
96% below
Market cap
$2.7M
Revenue (FY2025)
$13.8M
Revenue growth (10-yr CAGR)
2.5%
ROIC (10-yr avg)
-15.1%
Free cash flow (FY2025)
-$516.0K

CVSI 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $13.8M -$958.0K -$0.01 -$516.0K -3.4% -18.9%
FY2024 $15.7M -$2.4M -$0.01 -$879.0K -13.9% -118.6%
FY2023 $16.0M $3.1M $0.02 $2.3M 21.0% 1513.5%
FY2022 $16.2M -$8.2M -$0.07 -$1.9M -42.3% -1065.4%
FY2021 $20.0M -$15.6M -$0.14 -$7.5M -92.0% -218.9%
FY2020 $24.4M -$22.3M -$0.22 -$8.4M -92.5% -101.6%
FY2019 $53.7M -$16.6M -$0.17 -$3.3M -32.1% -56.2%
FY2018 $48.2M $10.0M $0.09 $11.7M 21.2% 43.7%
FY2017 $20.7M -$4.9M -$0.06 $3.2M -23.5% -29.9%
FY2016 $11.1M -$14.1M — -$2.1M -118.2% -99.0%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

CV Sciences, Inc. has demonstrated mature, steady growth, with revenue compounding at 2.5% annually over the past decade.

CV Sciences, Inc. has historically struggled to out-earn its cost of capital, averaging just -37.8% ROIC.

CV Sciences, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, CV Sciences, Inc. is modeled at 2.5% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.23 per share.

CVSI stock: frequently asked questions

What is the intrinsic value of Cv Sciences, Inc. (CVSI) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 2.5% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, CVSI's intrinsic value is about $0.23 per share.

Is CVSI stock undervalued?

At $0.01 (close on Oct 17, 2026), CVSI trades 96% below its Graham value of $0.23. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

How fast has Cv Sciences, Inc. grown?

Revenue went from $11.1M in fiscal 2016 to $13.8M in fiscal 2025, a compound annual growth rate of 2.5%. Net income was -$958.0K in fiscal 2025.

Does Cv Sciences, Inc. generate free cash flow?

Cv Sciences, Inc. generated -$516.0K of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 3 of the last 10 reported years.

What is CVSI's return on invested capital?

Average ROIC over the last 10 fiscal years was -15.1%, and average return on equity was -93.7%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this CVSI data come from?

From Cv Sciences, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 15, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks